全体要約
この研究によると、2029年までに世界の核酸医薬品市場規模は数百万米ドルに達する見込みです。
核酸医薬品市場は、製品タイプ、アプリケーション、主要プレーヤー、地域別に成長機会を提供します。製品タイプには、アンチセンス核酸医薬品、siRNA医薬品、saRNA医薬品、miRNA医薬品、mRNA医薬品などが含まれます。アプリケーションは、遺伝病、癌、心血管疾患などに分類されます。
市場は、アメリカ、中国、ヨーロッパ、日本、韓国、東南アジアなどの地域に分かれています。主要なプレーヤーには、Sarepta Therapeutics、Ionis Pharmaceuticals、Alnylam、Mina Therapeutics、BioNTech、Nippon Shinyaku、Moderna Therapeuticsなどが含まれます。
関連する質問
Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Mina Therapeutics, BioNTech, NeXstar Pharmaceuticals, Nippon Shinyaku, Moderna Therapeutics, CureVac, Regulus Therapeutics, Miragen Therapeutics
遺伝病治療の進展, がん治療の新しいアプローチ, 心血管疾患に対する新規治療法
概要
このレポートは、製品タイプ、アプリケーション、主要プレーヤー、主要地域および国別の核酸医薬品市場の包括的な概要、市場シェア、成長機会を提供します。
製品タイプによるセグメンテーション：
アンチセンス核酸薬
siRNA薬
saRNA 医薬品
miRNA医薬品
mRNA医薬品
その他
アプリケーションによるセグメンテーション：
遺伝性疾患
癌
心血管疾患
その他
この報告書は地域別に市場を分類しています。
アメリカ合衆国
中国
ヨーロッパ
その他の地域
日本
韓国
東南アジア
その他の地域
本報告書は、市場競争の状況と市場の主要プレーヤーに関する詳細な分析を提供。本報告書で取り上げられている主なプレーヤー：
サレプタ・セラピューティクス
アイオニス・ファーマシューティカルズ
アルナイラム
ミナ・セラピューティックス
バイオンテック
ネクスター・ファーマシューティカルズ
日本新薬
モデルナ・セラピューティクス
キュアバック
レグラス・セラピューティクス
ミラジェン・テラピューティクス
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの核酸医薬品市場規模、（2024年～2029年）
2.1.2 核酸医薬品市場規模、CAGR（地域別）
2.2 核酸医薬品セグメント、タイプ別
2.2.1 アンチセンス核酸医薬品
2.2.2 siRNA医薬品
2.2.3 saRNA医薬品
2.2.4 miRNA医薬品
2.2.5 mRNA医薬品
2.2.6 その他
2.3 核酸医薬品市場規模：タイプ別
2.3.1 グローバルの核酸医薬品市場規模、市場シェア（タイプ別）（2024年～2029年）
2.3.2 グローバルの核酸医薬品市場規模、成長率（タイプ別）（2024年～2029年）
2.4 核酸医薬品セグメント、用途別
2.4.1 遺伝子疾患
2.4.2 がん種
2.4.3 循環器系疾患
2.4.4 その他
2.5 核酸医薬品市場規模：用途別
2.5.1 グローバルの核酸医薬品市場規模、市場シェア（用途別）（2024年～2029年）
2.5.2 グローバルの核酸医薬品市場規模、成長率（用途別）（2024年～2029年）
3 核酸医薬品主要企業
3.1 主要プレイヤーの核酸医薬品市場への参入日
3.2 主要プレーヤーの核酸医薬品製品
3.3 主要プレーヤー 核酸医薬品の資金調達/投資分析
3.4 Funding/Investment
3.4.1 Funding/Investment、地域別
3.4.2 Funding/Investment、最終業界別
3.5 主要プレーヤーの核酸医薬品の評価額と時価総額
3.6 主要プレイヤーのM&A・事業拡大計画
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 核酸医薬品、地域別
4.1 核酸医薬品市場規模（地域別）（2024年～2029年）
4.2 米国における核酸医薬品市場規模成長（2024年〜2029年）
4.3 中国における核酸医薬品市場規模成長（2024年〜2029年）
4.4 ヨーロッパにおける核酸医薬品市場規模成長（2024年〜2029年）
4.5 その他地域における核酸医薬品市場規模成長（2024年〜2029年）
5 米国
5.1 米国における核酸医薬品市場規模、タイプ別（2024年〜2029年）
5.2 米国における核酸医薬品市場規模、用途別（2024年〜2029年）
6 ヨーロッパ
6.1 ヨーロッパにおける核酸医薬品市場規模、タイプ別（2024年〜2029年）
6.2 ヨーロッパにおける核酸医薬品市場規模、用途別（2024年〜2029年）
7 中国
7.1 中国における核酸医薬品市場規模、タイプ別（2024年〜2029年）
7.2 中国における核酸医薬品市場規模、用途別（2024年〜2029年）
8 その他地域
8.1 その他地域における核酸医薬品市場規模、タイプ別（2024年〜2029年）
8.2 その他地域における核酸医薬品市場規模、用途別（2024年〜2029年）
8.3 日本
8.4 韓国
8.5 東南アジア
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 核酸医薬品市場の主要投資家
10.1 Company A
10.1.1 Company A : 企業詳細
10.1.2 企業概要
10.1.3 A社の投資先
10.1.4 A社 主要開発と市場レイアウト
10.2 Company B
10.2.1 Company B : 企業詳細
10.2.2 企業概要
10.2.3 B社の投資先
10.2.4 B社 主要開発と市場レイアウト
10.3 Company C
10.3.1 Company C : 企業詳細
10.3.2 企業概要
10.3.3 C社の投資先
10.3.4 C社 主要開発と市場レイアウト
10.4 Company D
10.5 ……
11 キープレイヤー分析
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics : 企業詳細
11.1.2 Sarepta Therapeutics：核酸医薬品分野の提供製品
11.1.3 サレプタ・セラピューティクス 核酸医薬品の市場規模（2023年VS2029年）
11.1.4 Sarepta Therapeutics：主要事業概要
11.1.5 サレプタ・セラピューティクス ニュース
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals : 企業詳細
11.2.2 Ionis Pharmaceuticals：核酸医薬品分野の提供製品
11.2.3 イオニス・ファーマシューティカルズの核酸医薬品市場規模（2023年VS2029年）
11.2.4 Ionis Pharmaceuticals：主要事業概要
11.2.5 イオニス・ファーマシューティカルズ ニュース
11.3 Alnylam
11.3.1 Alnylam : 企業詳細
11.3.2 Alnylam：核酸医薬品分野の提供製品
11.3.3 アルニラム核酸医薬品の市場規模（2023 VS 2029）
11.3.4 Alnylam：主要事業概要
11.3.5 アルナイラム社ニュース
11.4 Mina Therapeutics
11.4.1 Mina Therapeutics : 企業詳細
11.4.2 Mina Therapeutics：核酸医薬品分野の提供製品
11.4.3 ミナ治療薬の核酸医薬品市場規模（2023年VS2029年）
11.4.4 Mina Therapeutics：主要事業概要
11.4.5 ミナ・セラピューティクス ニュース
11.5 BioNTech
11.5.1 BioNTech : 企業詳細
11.5.2 BioNTech：核酸医薬品分野の提供製品
11.5.3 BioNTech核酸医薬品の市場規模（2023 VS 2029）
11.5.4 BioNTech：主要事業概要
11.5.5 BioNTechニュース
11.6 NeXstar Pharmaceuticals
11.6.1 NeXstar Pharmaceuticals : 企業詳細
11.6.2 NeXstar Pharmaceuticals：核酸医薬品分野の提供製品
11.6.3 核酸医薬品の市場規模（2023年VS2029年）
11.6.4 NeXstar Pharmaceuticals：主要事業概要
11.6.5 ネクスター・ファーマシューティカルズ ニュース
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku : 企業詳細
11.7.2 Nippon Shinyaku：核酸医薬品分野の提供製品
11.7.3 日本新薬 核酸医薬品の市場規模（2023年VS2029年）
11.7.4 Nippon Shinyaku：主要事業概要
11.7.5 日本新薬ニュース
11.8 Moderna Therapeutics
11.8.1 Moderna Therapeutics : 企業詳細
11.8.2 Moderna Therapeutics：核酸医薬品分野の提供製品
11.8.3 Moderna Therapeutics 核酸医薬品の市場規模（2023年 VS 2029年）
11.8.4 Moderna Therapeutics：主要事業概要
11.8.5 モデナ・セラピューティクス ニュース
11.9 CureVac
11.9.1 CureVac : 企業詳細
11.9.2 CureVac：核酸医薬品分野の提供製品
11.9.3 キュアバック核酸医薬品の市場規模（2023年VS2029年）
11.9.4 CureVac：主要事業概要
11.9.5 CureVacニュース
11.10 Regulus Therapeutics
11.10.1 Regulus Therapeutics : 企業詳細
11.10.2 Regulus Therapeutics：核酸医薬品分野の提供製品
11.10.3 レグルス・セラピューティクス核酸医薬品の市場規模（2023年VS2029年）
11.10.4 Regulus Therapeutics：主要事業概要
11.10.5 レグルス・セラピューティクス ニュース
11.11 Miragen Therapeutics
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
Antisense Nucleic Acid Drugs
siRNA Drugs
saRNA Drugs
miRNA Drugs
mRNA Drugs
other
Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Mina Therapeutics
BioNTech
NeXstar Pharmaceuticals
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Miragen Therapeutics
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid Drugs Market Size 2024-2029
2.1.2 Nucleic Acid Drugs Market Size CAGR by Region
2.2 Nucleic Acid Drugs Segment by Type
2.2.1 Antisense Nucleic Acid Drugs
2.2.2 siRNA Drugs
2.2.3 saRNA Drugs
2.2.4 miRNA Drugs
2.2.5 mRNA Drugs
2.2.6 other
2.3 Nucleic Acid Drugs Market Size by Type
2.3.1 Global Nucleic Acid Drugs Market Size Market Share by Type (2024-2029)
2.3.2 Global Nucleic Acid Drugs Market Size Growth Rate by Type (2024-2029)
2.4 Nucleic Acid Drugs Segment by Application
2.4.1 Genetic Disease
2.4.2 Cancer
2.4.3 Cardiovascular Diseases
2.4.4 Other
2.5 Nucleic Acid Drugs Market Size by Application
2.5.1 Global Nucleic Acid Drugs Market Size Market Share by Application (2024-2029)
2.5.2 Global Nucleic Acid Drugs Market Size Growth Rate by Application (2024-2029)
3 Nucleic Acid Drugs Key Players
3.1 Date of Key Players Enter into Nucleic Acid Drugs
3.2 Key Players Nucleic Acid Drugs Product Offered
3.3 Key Players Nucleic Acid Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Nucleic Acid Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Nucleic Acid Drugs by Regions
4.1 Nucleic Acid Drugs Market Size by Regions (2024-2029)
4.2 United States Nucleic Acid Drugs Market Size Growth (2024-2029)
4.3 China Nucleic Acid Drugs Market Size Growth (2024-2029)
4.4 Europe Nucleic Acid Drugs Market Size Growth (2024-2029)
4.5 Rest of World Nucleic Acid Drugs Market Size Growth (2024-2029)
5 United States
5.1 United States Nucleic Acid Drugs Market Size by Type (2024-2029)
5.2 United States Nucleic Acid Drugs Market Size by Application (2024-2029)
6 Europe
6.1 Europe Nucleic Acid Drugs Market Size by Type (2024-2029)
6.2 Europe Nucleic Acid Drugs Market Size by Application (2024-2029)
7 China
7.1 China Nucleic Acid Drugs Market Size by Type (2024-2029)
7.2 China Nucleic Acid Drugs Market Size by Application (2024-2029)
8 Rest of World
8.1 Rest of World Nucleic Acid Drugs Market Size by Type (2024-2029)
8.2 Rest of World Nucleic Acid Drugs Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Nucleic Acid Drugs
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Details
11.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Offered
11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics News
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Details
11.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2023 VS 2029)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals News
11.3 Alnylam
11.3.1 Alnylam Company Details
11.3.2 Alnylam Nucleic Acid Drugs Product Offered
11.3.3 Alnylam Nucleic Acid Drugs Market Size (2023 VS 2029)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam News
11.4 Mina Therapeutics
11.4.1 Mina Therapeutics Company Details
11.4.2 Mina Therapeutics Nucleic Acid Drugs Product Offered
11.4.3 Mina Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029)
11.4.4 Mina Therapeutics Main Business Overview
11.4.5 Mina Therapeutics News
11.5 BioNTech
11.5.1 BioNTech Company Details
11.5.2 BioNTech Nucleic Acid Drugs Product Offered
11.5.3 BioNTech Nucleic Acid Drugs Market Size (2023 VS 2029)
11.5.4 BioNTech Main Business Overview
11.5.5 BioNTech News
11.6 NeXstar Pharmaceuticals
11.6.1 NeXstar Pharmaceuticals Company Details
11.6.2 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offered
11.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2023 VS 2029)
11.6.4 NeXstar Pharmaceuticals Main Business Overview
11.6.5 NeXstar Pharmaceuticals News
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Details
11.7.2 Nippon Shinyaku Nucleic Acid Drugs Product Offered
11.7.3 Nippon Shinyaku Nucleic Acid Drugs Market Size (2023 VS 2029)
11.7.4 Nippon Shinyaku Main Business Overview
11.7.5 Nippon Shinyaku News
11.8 Moderna Therapeutics
11.8.1 Moderna Therapeutics Company Details
11.8.2 Moderna Therapeutics Nucleic Acid Drugs Product Offered
11.8.3 Moderna Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029)
11.8.4 Moderna Therapeutics Main Business Overview
11.8.5 Moderna Therapeutics News
11.9 CureVac
11.9.1 CureVac Company Details
11.9.2 CureVac Nucleic Acid Drugs Product Offered
11.9.3 CureVac Nucleic Acid Drugs Market Size (2023 VS 2029)
11.9.4 CureVac Main Business Overview
11.9.5 CureVac News
11.10 Regulus Therapeutics
11.10.1 Regulus Therapeutics Company Details
11.10.2 Regulus Therapeutics Nucleic Acid Drugs Product Offered
11.10.3 Regulus Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029)
11.10.4 Regulus Therapeutics Main Business Overview
11.10.5 Regulus Therapeutics News
11.11 Miragen Therapeutics
12 Research Findings and Conclusion
List of Tables Table 1. Nucleic Acid Drugs Market Size CAGR by Region (2024-2029) ($ Millions) Table 2. Major Players of Antisense Nucleic Acid Drugs Table 3. Major Players of siRNA Drugs Table 4. Major Players of saRNA Drugs Table 5. Major Players of miRNA Drugs Table 6. Major Players of mRNA Drugs Table 7. Major Players of other Table 8. Global Nucleic Acid Drugs Market Size by Type (2024-2029) ($ Millions) Table 9. Global Nucleic Acid Drugs Market Size Market Share by Type (2024-2029) Table 10. Global Nucleic Acid Drugs Market Size by Application (2024-2029) ($ Millions) Table 11. Global Nucleic Acid Drugs Market Size Market Share by Application (2024-2029) Table 12. Date of Global Key Players Enter into Nucleic Acid Drugs Market Table 13. Global Key Players Nucleic Acid Drugs Product Offered Table 14. Key Players Nucleic Acid Drugs Funding/Investment ($ Millions) Table 15. Funding/Investment by Regions Table 16. Funding/Investment by End Industry Table 17. Key Players Nucleic Acid Drugs Valuation & Market Capitalization ($ Millions) Table 18. Key Players Mergers & Acquisitions, Expansion Plans Table 19. Nucleic Acid Drugs New Product/Technology Launches Table 20. Nucleic Acid Drugs Industry Partnerships, Agreements, and Collaborations Table 21. Nucleic Acid Drugs Industry Mergers and Acquisitions Table 22. Global Nucleic Acid Drugs Market Size by Regions 2024-2029 ($ Millions) Table 23. Global Nucleic Acid Drugs Market Size Market Share by Regions 2024-2029 Table 24. United States Nucleic Acid Drugs Market Size by Type (2024-2029) ($ Millions) Table 25. United States Nucleic Acid Drugs Market Size Market Share by Type (2024-2029) Table 26. United States Nucleic Acid Drugs Market Size by Application (2024-2029) ($ Millions) Table 27. United States Nucleic Acid Drugs Market Size Market Share by Application (2024-2029) Table 28. Europe Nucleic Acid Drugs Market Size by Type (2024-2029) ($ Millions) Table 29. Europe Nucleic Acid Drugs Market Size Market Share by Type (2024-2029) Table 30. Europe Nucleic Acid Drugs Market Size by Application (2024-2029) ($ Millions) Table 31. Europe Nucleic Acid Drugs Market Size Market Share by Application (2024-2029) Table 32. China Nucleic Acid Drugs Market Size by Type (2024-2029) ($ Millions) Table 33. China Nucleic Acid Drugs Market Size Market Share by Type (2024-2029) Table 34. China Nucleic Acid Drugs Market Size by Application (2024-2029) ($ Millions) Table 35. China Nucleic Acid Drugs Market Size Market Share by Application (2024-2029) Table 36. Rest of World Nucleic Acid Drugs Market Size by Type (2024-2029) ($ Millions) Table 37. Rest of World Nucleic Acid Drugs Market Size Market Share by Type (2024-2029) Table 38. Rest of World Nucleic Acid Drugs Market Size by Application (2024-2029) ($ Millions) Table 39. Rest of World Nucleic Acid Drugs Market Size Market Share by Application (2024-2029) Table 40. Key Market Drivers & Growth Opportunities of Nucleic Acid Drugs Table 41. Key Market Challenges & Risks of Nucleic Acid Drugs Table 42. Key Industry Trends of Nucleic Acid Drugs Table 43. Company A Company Details Table 44. Companies Invested by Company A Table 45. Company A Key Development and Market Layout Table 46. Company B Company Details Table 47. Companies Invested by Company B Table 48. Company B Key Development and Market Layout Table 49. Company C Company Details Table 50. Companies Invested by Company C Table 51. Company C Key Development and Market Layout Table 52. Company C Company Details Table 53. Companies Invested by Company C Table 54. Company C Key Development and Market Layout Table 55. Sarepta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 56. Sarepta Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029) Table 57. Ionis Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors Table 58. Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2023 VS 2029) Table 59. Alnylam Basic Information, Head Office, Major Market Areas and Its Competitors Table 60. Alnylam Nucleic Acid Drugs Market Size (2023 VS 2029) Table 61. Mina Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 62. Mina Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029) Table 63. BioNTech Basic Information, Head Office, Major Market Areas and Its Competitors Table 64. BioNTech Nucleic Acid Drugs Market Size (2023 VS 2029) Table 65. NeXstar Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors Table 66. NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2023 VS 2029) Table 67. Nippon Shinyaku Basic Information, Head Office, Major Market Areas and Its Competitors Table 68. Nippon Shinyaku Nucleic Acid Drugs Market Size (2023 VS 2029) Table 69. Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 70. Moderna Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029) Table 71. CureVac Basic Information, Head Office, Major Market Areas and Its Competitors Table 72. CureVac Nucleic Acid Drugs Market Size (2023 VS 2029) Table 73. Regulus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 74. Regulus Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029) Table 75. Miragen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 76. Miragen Therapeutics Nucleic Acid Drugs Market Size (2023 VS 2029) List of Figures Figure 1. Picture of Nucleic Acid Drugs Figure 2. Nucleic Acid Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Nucleic Acid Drugs Market Size Growth Rate 2024-2029 ($ Millions) Figure 7. Nucleic Acid Drugs Market Size by Region (2023 & 2029) ($ millions) Figure 8. Global Nucleic Acid Drugs Market Size Market Share by Type (2024-2029) Figure 9. Global Antisense Nucleic Acid Drugs Market Size Growth Rate Figure 10. Global siRNA Drugs Market Size Growth Rate Figure 11. Global saRNA Drugs Market Size Growth Rate Figure 12. Global miRNA Drugs Market Size Growth Rate Figure 13. Global mRNA Drugs Market Size Growth Rate Figure 14. Global other Market Size Growth Rate Figure 15. Nucleic Acid Drugs in Genetic Disease Figure 16. Global Nucleic Acid Drugs Market: Genetic Disease (2024-2029) ($ Millions) Figure 17. Nucleic Acid Drugs in Cancer Figure 18. Global Nucleic Acid Drugs Market: Cancer (2024-2029) ($ Millions) Figure 19. Nucleic Acid Drugs in Cardiovascular Diseases Figure 20. Global Nucleic Acid Drugs Market: Cardiovascular Diseases (2024-2029) ($ Millions) Figure 21. Nucleic Acid Drugs in Other Figure 22. Global Nucleic Acid Drugs Market: Other (2024-2029) ($ Millions) Figure 23. Global Nucleic Acid Drugs Market Size Market Share by Application (2024-2029) Figure 24. Global Nucleic Acid Drugs Market Size in Genetic Disease Growth Rate Figure 25. Global Nucleic Acid Drugs Market Size in Cancer Growth Rate Figure 26. Global Nucleic Acid Drugs Market Size in Cardiovascular Diseases Growth Rate Figure 27. Global Nucleic Acid Drugs Market Size in Other Growth Rate Figure 28. Funding/Investment Figure 29. Global Nucleic Acid Drugs Market Size Market Share by Regions 2024-2029 Figure 30. United States Nucleic Acid Drugs Market Size 2024-2029 ($ Millions) Figure 31. China Nucleic Acid Drugs Market Size 2024-2029 ($ Millions) Figure 32. Europe Nucleic Acid Drugs Market Size 2024-2029 ($ Millions) Figure 33. Rest of World Nucleic Acid Drugs Market Size 2024-2029 ($ Millions) Figure 34. United States Nucleic Acid Drugs Consumption Market Share by Type in 2029 Figure 35. United States Nucleic Acid Drugs Market Size Market Share by Application in 2029 Figure 36. China Nucleic Acid Drugs Consumption Market Share by Type in 2029 Figure 37. China Nucleic Acid Drugs Market Size Market Share by Application in 2029 Figure 38. Europe Nucleic Acid Drugs Consumption Market Share by Type in 2029 Figure 39. Europe Nucleic Acid Drugs Market Size Market Share by Application in 2029 Figure 40. Rest of World Nucleic Acid Drugs Consumption Market Share by Type in 2029 Figure 41. Rest of World Nucleic Acid Drugs Market Size Market Share by Application in 2029
